Medical devices, healthcare technology and the business of care
510(k) clearance · K260767

Facial Beauty Device (Facial Mask LED Beauty Device A-901; Facial LED & EMS Beauty Device A-902; Facial Mask LED & EMS Beauty Device A-907)

Kam Yuen Plastic Products , Ltd. · Decision date Aug 31, 2026

FDA DECISIONK260767

What did the FDA decide?

FDA records K260767 as a 510(k) premarket notification, with a decision dated Aug 31, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Aug 31, 2026

FDA source record

Regulatory record facts

Identifier
K260767
Regulatory pathway
510(k) premarket notification
Product code
OHS
Decision code
SESE
Decision date
Aug 31, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light Based Over The Counter Wrinkle Reduction.

Product code
OHS
FDA device class
2

FDA decision timeline

  1. K260767 received

    Application receipt date recorded by FDA.

  2. K260767 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OHS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kam Yuen Plastic Products , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Zhongshan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records